{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:13:32Z","timestamp":1761664412502,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.reuma.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:51:50Z","timestamp":1537264310000},"page":"324-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Eficacia y seguridad de la terapia combinada con f\u00e1rmacos modificadores de la enfermedad sint\u00e9ticos en la artritis reumatoide: revisi\u00f3n sistem\u00e1tica de la literatura"],"prefix":"10.1016","volume":"16","author":[{"given":"Jaime","family":"Calvo Al\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Romero Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Alegre Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Pinto Tasende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Maceiras Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Vanesa","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Hidalgo Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"San Mart\u00edn \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel Tevar","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimon","family":"Sanmart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2018.07.016_bib0175","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0185","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-017-3962-5","article-title":"Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice","author":"Versteeg","year":"2018","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.reuma.2018.07.016_bib0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00296-017-3695-4","article-title":"Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study","volume":"37","author":"De Andrade","year":"2017","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2018.07.016_bib0195","doi-asserted-by":"crossref","first-page":"e000404","DOI":"10.1136\/rmdopen-2016-000404","article-title":"Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis","volume":"3","author":"Daien","year":"2017","journal-title":"RMD Open."},{"key":"10.1016\/j.reuma.2018.07.016_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.semarthrit.2015.11.004","article-title":"Subcutaneous administration of methotrexate at high doses makes a better performance in the treatment of rheumatoid arthritis compared with oral administration of methotrexate: A systematic review and meta-analysis","volume":"45","author":"Li","year":"2016","journal-title":"Semin Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.reuma.2018.07.016_bib0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20452\/pamw.1131","article-title":"Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials","volume":"122","author":"Golicki","year":"2012","journal-title":"Pol Arch Med Wewn."},{"key":"10.1016\/j.reuma.2018.07.016_bib0210","unstructured":"Sociedad Espa\u00f1ola de Reumatolog\u00eda. GUPCAR. 2015."},{"key":"10.1016\/j.reuma.2018.07.016_bib0215","first-page":"279","article-title":"2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis","volume":"11","author":"Sanmarti","year":"2015","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2018.07.016_bib0220","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2016-210602","article-title":"2016 update of the EULAR recommendations for the management of early arthritis","volume":"76","author":"Combe","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"10.1016\/j.reuma.2018.07.016_bib0235","unstructured":"CEBM., Medicine. CfEB. CEBM Levels of Evidence 2011.: University of Oxford; 2011."},{"key":"10.1016\/j.reuma.2018.07.016_bib0240","doi-asserted-by":"crossref","first-page":"e000143","DOI":"10.1136\/rmdopen-2015-000143","article-title":"Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial","volume":"2","author":"Akdemir","year":"2016","journal-title":"RMD Open."},{"issue":"6 Suppl 43","key":"10.1016\/j.reuma.2018.07.016_bib0245","article-title":"Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study","volume":"24","author":"Allaart","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.reuma.2018.07.016_bib0250","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","article-title":"Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial","volume":"146","author":"Goekoop-Ruiterman","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.reuma.2018.07.016_bib0255","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.07.016_bib0260","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2007.086348","article-title":"Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis","volume":"68","author":"Guler-Yuksel","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0265","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2007.073817","article-title":"Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis","volume":"67","author":"Guler-Yuksel","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0270","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/ard.2010.141234","article-title":"The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"4 Suppl 73","key":"10.1016\/j.reuma.2018.07.016_bib0275","first-page":"S35","article-title":"BeSt practice: the success of early-targeted treatment in rheumatoid arthritis","volume":"30","author":"Van den Broek","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.reuma.2018.07.016_bib0280","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/ard.2006.066662","article-title":"Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score","volume":"66","author":"Van der Kooij","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0285","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ard.2008.092254","article-title":"Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis","volume":"68","author":"Van der Kooij","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.07.016_bib0290","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/rheumatology\/kes228","article-title":"Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints","volume":"51","author":"Dirven","year":"2012","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2018.07.016_bib0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-015-0730-2","article-title":"Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study","volume":"17","author":"Markusse","year":"2015","journal-title":"Arthritis Res Ther."},{"issue":"2 Suppl","key":"10.1016\/j.reuma.2018.07.016_bib0300","first-page":"S126","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial","volume":"58","author":"Goekoop-Ruiterman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.07.016_bib0305","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/rheumatology\/keu235","article-title":"Short-term efficacy of etanercept plus methotrexate vs.combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis","volume":"53","author":"Fleischmann","year":"2014","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2018.07.016_bib0310","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","article-title":"Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial","volume":"137","author":"Kremer","year":"2002","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.reuma.2018.07.016_bib0315","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12891-017-1673-3","article-title":"Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial","volume":"18","author":"Wijesinghe","year":"2017","journal-title":"BMC Musculoskelet Disord."},{"key":"10.1016\/j.reuma.2018.07.016_bib0320","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/acr.23255","article-title":"Rheumatoid arthritis treatment after methotrexate: The durability of triple therapy versus etanercept","volume":"69","author":"Peper","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.reuma.2018.07.016_bib0325","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/art.38012","article-title":"Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial","volume":"65","author":"O\u2019Dell","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.07.016_bib0330","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O\u2019Dell","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reuma.2018.07.016_bib0335","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.10228","article-title":"Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial","volume":"46","author":"O\u2019Dell","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.07.016_bib0340","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/annrheumdis-2015-208941","article-title":"Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial","volume":"75","author":"Dale","year":"2016","journal-title":"Ann Rheum Dis."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1830175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1830175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:59:49Z","timestamp":1761663589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X1830175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1699258X1830175X"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2018.07.016","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eficacia y seguridad de la terapia combinada con f\u00e1rmacos modificadores de la enfermedad sint\u00e9ticos en la artritis reumatoide: revisi\u00f3n sistem\u00e1tica de la literatura","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}